» Articles » PMID: 34341702

Limb Remote Ischemic Conditioning Ameliorates Cognitive Impairment in Rats with Chronic Cerebral Hypoperfusion by Regulating Glucose Transport

Overview
Journal Aging Dis
Specialty Geriatrics
Date 2021 Aug 3
PMID 34341702
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cognitive impairment is closely associated with the slowing of glucose metabolism in the brain. Glucose transport, a rate-limiting step of glucose metabolism, plays a key role in this phenomenon. Previous studies have reported that limb remote ischemic conditioning (LRIC) improves cognitive performance in rats with chronic cerebral hypoperfusion (CCH). Here, we determined whether LRIC could ameliorate cognitive impairment in rats with CCH by regulating glucose transport. A total of 170 male Sprague-Dawley rats were used. Animals subjected to permanent double carotid artery occlusion (2VO) were assigned to the control or LRIC treatment group. LRIC was applied beginning 3 days after the 2VO surgery. We found that LRIC can improve learning and memory; decrease the ratio of ADP/ATP; increase glucose content; upregulate the expression of pAMPKα, GLUT1 and GLUT3; and increase the number of GLUT1 and GLUT3 transporters in cerebral cortical neurons. The expression of GLUT1 and GLUT3 in the cortex displayed a strong correlation with learning and memory. Pearson correlation analysis showed that the levels of GLUT1 and GLUT3 are correlated with neurological function scores. All of these beneficial effects of LRIC were ablated by application of the AMPK inhibitor, dorsomorphin. In summary, LRIC ameliorated cognitive impairment in rats with CCH by regulating glucose transport via the AMPK/GLUT signaling pathway. We conclude that AMPK-mediated glucose transport plays a key role in LRIC. These data also suggest that supplemental activation of glucose transport after CCH may provide a clinically applicable intervention for improving cognitive impairment.

Citing Articles

Beyond Pharmacology: The Biological Mechanisms of Remote Ischemic Conditioning in Cerebrovascular Disease.

Qin L, Tong F, Li S, Ren C Biomolecules. 2024; 14(11).

PMID: 39595584 PMC: 11592304. DOI: 10.3390/biom14111408.


Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications.

Cheng J, Hu H, Ju Y, Liu J, Wang M, Liu B Gen Psychiatr. 2024; 37(1):e101374.

PMID: 38390241 PMC: 10882305. DOI: 10.1136/gpsych-2023-101374.


Combination of Atractylenolide I, Atractylenolide III, and Paeoniflorin promotes angiogenesis and improves neurological recovery in a mouse model of ischemic Stroke.

Li H, Yu W, Yang Y, Li S, Xu J, Gao C Chin Med. 2024; 19(1):3.

PMID: 38178130 PMC: 10768365. DOI: 10.1186/s13020-023-00872-z.


Abdominal Aortic Occlusion and the Inflammatory Effects in Heart and Brain.

Xu J, Li S, Wehbe A, Ji X, Yang Y, Yang Y Mediators Inflamm. 2023; 2023:2730841.

PMID: 38131062 PMC: 10735730. DOI: 10.1155/2023/2730841.


Hexahydrocurcumin Attenuates Neuronal Injury and Modulates Synaptic Plasticity in Chronic Cerebral Hypoperfusion in Rats.

Jearjaroen P, Thangwong P, Tocharus C, Lungkaphin A, Chaichompoo W, Srijun J Mol Neurobiol. 2023; 61(7):4304-4317.

PMID: 38087168 DOI: 10.1007/s12035-023-03821-x.


References
1.
Tang M, Gao G, Rueda C, Yu H, Thibodeaux D, Awano T . Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein. Nat Commun. 2017; 8:14152. PMC: 5263887. DOI: 10.1038/ncomms14152. View

2.
Sato N, Morishita R . Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors. Front Aging Neurosci. 2013; 5:64. PMC: 3817366. DOI: 10.3389/fnagi.2013.00064. View

3.
Curry D, Stutz B, Andrews Z, Elsworth J . Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease. J Parkinsons Dis. 2018; 8(2):161-181. PMC: 6004921. DOI: 10.3233/JPD-171296. View

4.
Wang Z, Zhao F, Wang C, Zhang X, Xiao Y, Zhou F . Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease. J Alzheimers Dis. 2019; 72(4):1217-1231. DOI: 10.3233/JAD-190796. View

5.
Sun J, Tong L, Luan Q, Deng J, Li Y, Li Z . Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channels in a rat model of focal cerebral ischemic reperfusion injury. J Cereb Blood Flow Metab. 2012; 32(5):851-9. PMC: 3345910. DOI: 10.1038/jcbfm.2011.199. View